Application Of Xiaoke Pill in Treatment of Type 2 Diabetes Mellitus

Authors

  • Ruiqi Lu

DOI:

https://doi.org/10.54097/k11zg868

Keywords:

Type 2 diabetes mellitus, Xiaoke pill, traditional Chinese medicine.

Abstract

As a metabolic chronic disease, the number of patients with diabetes and its fatality rate remain high. At present, many drugs have been developed for the prevention and treatment of diabetes, such as glibenclamide, insulin and other drugs in the clinical treatment of diabetes, has achieved very good therapeutic effects. However, there are research on the treatment of diabetes with traditional Chinese medicine (TCM). In this paper, through the dissolving analysis of Xiaoke Pill, the action mechanism and effect of the effective ingredients in Xiaoke pill for the treatment of diabetes were specifically analyzed, and it was found that the main ingredients in Xiaoke pill were effective for the treatment of diabetes, and could minimize the incidence of adverse consequences like hypoglycemia. Through the analysis and research of Xiaoke Pill, this paper hopes to provide theoretical help for TCM treatment of diabetes, and hope to increase the intensity of TCM treatment of diabetes.

Downloads

Download data is not yet available.

References

[1] International Diabetes Federation. Facts & Figures [EB/OL]. [2024-08-05]. https://idf.org/about-diabetes/diabetes-facts-figures/.

[2] WHO. Diabetes [EB/OL]. [2024-08-05]. https://www.who.int/zh/news-room/fact-sheets/detail/diabetes.

[3] Yu Du, Haitong Wan, Ping Huang. A critical review of Astragalus polysaccharides: From therapeutic mechanisms to pharmaceutics[J]. Biomedicine & Pharmacotherapy, 2022.

[4] Wang J, Ma Q, Li Y. Research progress on Traditional Chinese Medicine syndromes of diabetes mellitus[J]. Biomedicine & Pharmacotherapy, 2020.

[5] Dou Z, Xia Y, Zang J. Syndrome Differentiation and Treatment Regularity in Traditional Chinese Medicine for Type 2 Diabetes: A Text Mining Analysis[J]. Frontiers in Endocrinology, 2021.

[6] Pharmacopoeia of the People's Republic of China [EB/OL]. [2024-08-05]. https://ydz.chp.org.cn/#/item?bookId=1&entryId=1891.

[7] Pharmacopoeia of the People's Republic of China [EB/OL]. [2024-08-06]. https://ydz.chp.org.cn/#/item?bookId=1&entryId=527.

[8] Meng X, Liu X, Tan J. From Xiaoke to diabetes mellitus: a review of the research progress in traditional Chinese medicine for diabetes mellitus treatment[J]. Chinese Medicine, 2023.

[9] Wang S, Zhang S, Wang S. A comprehensive review on Pueraria: Insights on its chemistry and medicinal value[J/OL]. Biomedicine & Pharmacotherapy, 2020.

[10] Pharmacopoeia of the People's Republic of China [EB/OL]. [2024-08-06]. https://ydz.chp.org.cn/#/item?bookId=1&entryId=190.

[11] Li Y, Chen Q, Sun H J. The Active Ingredient Catalpol in Rehmannia glutinosa Reduces Blood Glucose in Diabetic Rats via the AMPK Pathway[J]. Diabetes, Metabolic Syndrome and Obesity, 2024, 17: 1761-1767.

[12] Pharmacopoeia of the People's Republic of China [EB/OL]. [2024-08-06]. https://ydz.chp.org.cn/#/item?bookId=1&entryId=479.

[13] Ren X Y, Liu Y Y, Hua H H. Based on network pharmacology and experiments to explore the potential mechanism of Radix Puerariae-Radix Trichosanthis and Radix Astragali-Radix Rehmanniae in the treatment of T2DM, 2022.

[14] Pharmacopoeia of the People's Republic of China [EB/OL]. [2024-08-06]. https://ydz.chp.org.cn/#/item?bookId=1&entryId=79.

[15] Pharmacopoeia of the People's Republic of China [EB/OL]. [2024-08-06]. https://ydz.chp.org.cn/#/item?bookId=1&entryId=381.

[16] Nowak A, Zaklos-Szyda M, Blasiak J. Potential of Schisandra chinensis (Turcz.) Baill. in Human Health and Nutrition: A Review of Current Knowledge and Therapeutic Perspectives[J]. Nutrients, 2019, 11(2): 333.

[17] Pharmacopoeia of the People's Republic of China [EB/OL]. [2024-08-06]. https://ydz.chp.org.cn/#/item?bookId=1&entryId=39.

[18] Alharazi W Z, Mcgowen A, Rose P. Could consumption of yam (Dioscorea) or its extract be beneficial in controlling glycaemia: a systematic review[J]. British Journal of Nutrition, 2022, 128(4): 613-624.

[19] Epping J, Laibach N. An underutilized orphan tuber crop—Chinese yam: a review[J]. Planta, 2020, 252(4): 58.

[20] Hardin M D, Jacobs T F. Glyburide[M/OL]. StatPearls. Treasure Island (FL): StatPearls Publishing, 2024[2024-08-08]. http://www.ncbi.nlm.nih.gov/books/NBK545313/.

[21] Wang Z M. Safety analysis of Xiaoke pill in the treatment of patients with type 2 diabetes mellitus[J]. China Medicine Guide, 2020, 18(04): 6+17.

[22] Li A J. Efficacy analysis of Xiaoke pill in treating patients with diabetes mellitus with deficiency of both qi and yin[J]. New World of Diabetes, 2021, 24(08): 31-34.

[23] Liu G, Huang Z, Xin Q. Cost-Effectiveness of Oral Antidiabetic Drugs: A Prospective Multicenter Study of Real-World Patients[J]. Evidence-based Complementary and Alternative Medicine: eCAM, 2021.

Downloads

Published

24-12-2024

How to Cite

Lu, R. (2024). Application Of Xiaoke Pill in Treatment of Type 2 Diabetes Mellitus. Highlights in Science, Engineering and Technology, 123, 249-254. https://doi.org/10.54097/k11zg868